European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC

A Nast; P Gisondi; A D Ormerod; P Saiag; C Smith; P I Spuls; P Arenberger; H Bachelez; J Barker; E Dauden; E M de Jong; E Feist; A Jacobs; R Jobling; L Kemény; M Maccarone; U Mrowietz; K A Papp; C Paul; K Reich; S Rosumeck; T Talme; H B Thio; P van de Kerkhof; R N Werner; N Yawalkar

doi:10.1111/jdv.13354

European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC

J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2277-94. doi: 10.1111/jdv.13354. Epub 2015 Oct 19.

Authors

A Nast¹, P Gisondi², A D Ormerod³, P Saiag⁴, C Smith⁵, P I Spuls⁶, P Arenberger⁷, H Bachelez⁸, J Barker⁹, E Dauden¹⁰, E M de Jong¹¹, E Feist¹², A Jacobs¹, R Jobling¹³, L Kemény¹⁴, M Maccarone¹⁵, U Mrowietz¹⁶, K A Papp¹⁷, C Paul¹⁸, K Reich¹⁹, S Rosumeck¹, T Talme²⁰, H B Thio²¹, P van de Kerkhof²², R N Werner¹, N Yawalkar²³

Affiliations

¹ Division of Evidence Based Medicine, Department of Dermatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
² Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
³ Department of Dermatology, Aberdeen Royal Infirmary, Aberdeen, UK.
⁴ Service de Dermatologie, Hôpital Ambroise Paré Université Paris V, Boulogne, France.
⁵ Clinical Lead for Dermatology, St Johns Institute of Dermatology, St Thomas' Hospital, London, UK.
⁶ Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands.
⁷ Third Faculty of Medicine, Department of Dermatology, Charles University, Prague, Czech Republic.
⁸ Department of Dermatology, Hôpital Saint-Louis, Paris, France.
⁹ St. Johns Institute of Dermatology, St. Thomas' Hospital, London, UK.
¹⁰ Hospital Universitario de la Princesa, Madrid, Spain.
¹¹ University Medical Center Nijmegen St Radboud, Nijmegen, The Netherlands.
¹² Medizinische Klinik mit Schwerpunkt Rheumatologie u. klinische Immonologie, Charité - Universitätsmedizin Berlin, Berlin, Germany.
¹³ Cambridge, UK.
¹⁴ SZTE Borgyogyaszati Klinika, Szeged, Hungary.
¹⁵ Roma, Italy.
¹⁶ Department of Dermatology, Psoriasis-Center University Medical Center Schleswig Holstein, Kiel, Germany.
¹⁷ Waterloo, Canada.
¹⁸ Department of Dermatology, Paul Sabatier University, Toulouse, France.
¹⁹ Dermatologikum Hamburg, Hamburg, Germany.
²⁰ Section of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
²¹ Department of Dermatology, Erasmus University, Rotterdam, The Netherlands.
²² Department of Dermatology, University Hospital Nijmegen, Nijmegen, The Netherlands.
²³ Department of Dermatology, Inselspital, Universitätsklinik für Dermatologie, Bern, Switzerland.

PMID: 26481193
DOI: 10.1111/jdv.13354

No abstract available

Publication types

Practice Guideline
Research Support, Non-U.S. Gov't

MeSH terms

Acitretin / therapeutic use
Adalimumab / therapeutic use
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Cyclosporine / therapeutic use
Drug Therapy, Combination
Etanercept / therapeutic use
Fumarates / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use*
Keratolytic Agents / therapeutic use
Methotrexate / therapeutic use
Psoriasis / drug therapy*
Ustekinumab / therapeutic use

Substances

Anti-Inflammatory Agents, Non-Steroidal
Fumarates
Immunosuppressive Agents
Keratolytic Agents
Cyclosporine
Ustekinumab
Adalimumab
Acitretin
Etanercept
Methotrexate